Health Care Equipment & Services

Artivion insider buys reveal confidence in rare‑disease pipeline & potential price impact.

Progyny CFO’s insider buying signals confidence in the company’s fertility‑benefits growth model, offering investors a potential long‑term upside amid recent stock dips.

Discover how Evolent Health’s CEO and execs’ buy‑sell patterns reveal nuanced confidence, PSU stakes, and sector risks—insightful for investors.

Progyny execs buying shares & options—insider confidence signals an undervalued stock amid fertility‑benefit growth, clinic expansion & potential upside.

Insider sales by Alignment Healthcare’s top execs reveal strategic portfolio play, not panic, as the firm navigates value‑based reimbursement and tech adoption to unlock recurring revenue.

Insider trades at Elevance Health reveal a mix of confidence and caution amid CMS challenges—CEO buys signal long‑term belief, while executive sells hint at short‑term volatility. Understand the full picture.

NeuroPace insider selling signals cautious confidence: CMO and CEO offload shares amid price dips, negative earnings and volatile market—investors weigh rebalancing vs. risk.

Quest Diagnostics insider sale by EVP Catherine Doherty: routine tax‑planning moves amid steady growth, no price impact, and a continued confidence signal for shareholders.

GE Healthcare’s insider buys and $35 M BARDA deal spotlight an AI‑driven ultrasound platform that could cut trauma diagnosis time by 12 min, boost survival, and ignite investor confidence.

Inside Lantheus Holdings’ March 2 insider trades reveal execs’ confidence, disciplined selling, and a strategic shift toward oncology diagnostics—key for investors to know.